Dynavax to Report First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020
April 23 2020 - 4:10PM
Dynavax Technologies Corporation (Nasdaq: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, will report first quarter 2020 financial results on
Thursday, May 7, 2020, after the U.S. financial markets close.
Dynavax will host a conference call and live
audio webcast on Thursday, May 7, 2020 at 4:30 p.m. (ET)/1:30 p.m.
(PT).
The live audio webcast may be accessed through
the “Events & Presentations” page on the “Investors” section of
the Company’s website at www.dynavax.com. Alternatively,
participants may dial (866) 420-4066 (domestic) or (409) 217-8237
(international) and refer to conference ID 1178679. A replay
of the webcast will be available for 30 days following the live
event.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. Dynavax is also
advancing CpG 1018 as a premier vaccine adjuvant through research
collaborations and partnerships. For more information, visit
www.dynavax.com and follow the company on LinkedIn.
Contacts:Nicole Arndt, Senior Manager, Investor
Relationsnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations Advisory Solutions
derek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024